200P-500-HI fetal bovine serum
Ended Awarded
- Contract number
- HHSN266NCG31212
- Awardee
-
Biosource International Incorporated UEI LNZ9JJ6N8U86
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,180
Award facts
- Contract value
-
- $4,180.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN266NCG31212?
HHSN266NCG31212 was awarded to Biosource International Incorporated by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 19, 2005.
How much is contract HHSN266NCG31212 worth?
The government has obligated $4,180 on HHSN266NCG31212.
Which agency awarded contract HHSN266NCG31212?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded HHSN266NCG31212, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN266NCG31212 an order under another contract?
Yes. HHSN266NCG31212 is a BPA call under HHSN263200500062483B, a blanket purchase agreement.
Was contract HHSN266NCG31212 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award